Antioxidant properties of HDL

被引:129
作者
Soran, Handrean [1 ,2 ]
Schofield, Jonathan D. [1 ,2 ]
Durrington, Paul N. [1 ]
机构
[1] Univ Manchester, Core Technol Facil, Cardiovasc Res Grp, Manchester M13 9NT, Lancs, England
[2] Cent Manchester Univ Hosp NHS Fdn Trust, Cardiovasc Trials Unit, Manchester, Lancs, England
关键词
apolipoprotein A1; glycated low-density lipoprotein; high-density lipoprotein; oxidized low-density lipoprotein; paraoxonase; 1; HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; PARAOXONASE GENE POLYMORPHISMS; OXIDATIVE MODIFICATION; APOLIPOPROTEIN M; PON1; GLYCATION; LDL; METABOLISM; MICE;
D O I
10.3389/fphar.2015.00222
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
High-density lipoprotein (HDL) provides a pathway for the passage of lipid peroxides and lysophospholipids to the liver via hepatic scavenger receptors. Perhaps more importantly, HDL actually metabolizes lipid hydroperoxides preventing their accumulation on low-density lipoprotein (LDL), thus impeding its atherogenic structural modification. A number of candidates have been suggested to be responsible for HDL's antioxidant function, with paraoxonase-1 (PON1) perhaps the most prominent. Here we review the evidence for HDL anti-oxidative function and the potential contributions of apolipoproteins, lipid transfer proteins, paraoxonases and other enzymes associated with HDL.
引用
收藏
页数:6
相关论文
共 51 条
[1]  
Bajaj Priyanka, 2014, ScientificWorldJournal, V2014, P854391, DOI 10.1155/2014/854391
[2]   Catalytic Stimulation by Restrained Active-Site Floppiness-The Case of High Density Lipoprotein-Bound Serum Paraoxonase-1 [J].
Ben-David, Moshe ;
Sussman, Joel L. ;
Maxwel, Christopher L. ;
Szeler, Klaudia ;
Kamerlin, Shina C. L. ;
Tawfik, Dan S. .
JOURNAL OF MOLECULAR BIOLOGY, 2015, 427 (06) :1359-1374
[3]   Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk [J].
Bhattacharyya, Tamali ;
Nicholls, Stephen J. ;
Topol, Eric J. ;
Zhang, Renliang ;
Yang, Xia ;
Schmitt, David ;
Fu, Xiaoming ;
Shao, Mingyuan ;
Brennan, Danielle M. ;
Ellis, Stephen G. ;
Brennan, Marie-Luise ;
Allayee, Hooman ;
Lusis, Aldons J. ;
Hazen, Stanley L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (11) :1265-1276
[4]   Apolipoprotein M in lipid metabolism and cardiometabolic diseases [J].
Borup, Anna ;
Christensen, Pernille M. ;
Nielsen, Lars B. ;
Christoffersen, Christina .
CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (01) :48-55
[5]   Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dip [J].
Cherry, N ;
Mackness, M ;
Durrington, P ;
Povey, A ;
Dippnall, M ;
Smith, T ;
Mackness, B .
LANCET, 2002, 359 (9308) :763-764
[6]  
CHRISTISON JK, 1995, J LIPID RES, V36, P2017
[7]  
Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5
[8]   Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities [J].
Draganov, DI ;
Teiber, JF ;
Speelman, A ;
Osawa, Y ;
Sunahara, R ;
La Du, BN .
JOURNAL OF LIPID RESEARCH, 2005, 46 (06) :1239-1247
[9]   Paraoxonase and atherosclerosis [J].
Durrington, PN ;
Mackness, B ;
Mackness, MI .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) :473-480
[10]   Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits [J].
Duverger, N ;
Kruth, H ;
Emmanuel, F ;
Caillaud, JM ;
Viglietta, C ;
Castro, G ;
Tailleux, A ;
Fievet, C ;
Fruchart, JC ;
Houdebine, LM ;
Denefle, P .
CIRCULATION, 1996, 94 (04) :713-717